IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Lamond Capital Partners LLC

Q4 2015 Holdings

Filed 2016-02-09 | 7 holdings | $17.8M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗

Amended (2016-02-09) | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)ACOM00287Y109$17.8M300,00099.7%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$10.5M100,00098.8%
Amgen Inc(AMGN)CallCOM031162100$20.7K150,0000.2%
Oracle Corp(ORCL)ACOM68389X105$18.3K500,0000.1%
Oracle Corp(ORCL)CallCOM68389X105$18.1K500,0000.2%
Ocular Therapeutix Inc(OCUL)COM67576A100$17.3K1,233,2850.2%
Puma Biotechnology Inc(PBYI)ACOM74587V107$17.3K220,7800.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$15.6K100,0000.1%
Abbvie Inc(ABBV)CallCOM00287Y109$13.6K250,0000.1%
Amgen Inc(AMGN)ACOM031162100$12.2K75,0000.1%
GW Pharmaceuticals PLCADS36197T103$11.0K120,0000.1%
Cypress Semiconductor Corp(CYEUR)COM232806109$9.4K1,100,0000.1%
Kite Pharma IncCallCOM49803L109$3.5K63,4000.0%
Ignyta IncACOM451731103$62646,7210.0%
Zeltiq Aesthetics IncACOM98933Q108$46016,1190.0%
Immunomedics Inc(IMMU)ACOM452907108$307100,0000.0%